These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36097882)

  • 1. Adverse cutaneous reactions reported post COVID-19 vaccination in Al Buraimi governorate, Sultanate of Oman.
    Al Salmi A; Al Khamisani M; Al Shibli A; Al Maqbali S
    Dermatol Ther; 2022 Nov; 35(11):e15820. PubMed ID: 36097882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global incidence pattern and factors associated with common cutaneous reactions related to COVID-19 vaccination of 2.55 million participants in real-world settings: A systematic review and meta-analysis.
    Guo Y; Cao XS; Yang HT; Zhou MG; Yu B
    J Glob Health; 2023 Feb; 13():06008. PubMed ID: 36757823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical observation and analysis of skin reactions caused by COVID-19 vaccination.
    Li Y; Fan L; Mao Q; Luan X; Wang Z; Zeng N; Cheng Y; Li Y; Xia Q; Lu Z; Lu Q; Min W; Luo D
    Dermatol Ther; 2022 Oct; 35(10):e15746. PubMed ID: 36190010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin manifestations following anti-COVID-19 vaccination: A multicentricstudy from Turkey.
    Oguz Topal I; Tokmak A; Kurmuş GI; Kalkan G; Demirseren DD; Tosun M; Emre S; Özkök Akbulut T; Kaya Özden H; Koska MC; Külcü Çakmak S; Kutlu Ö; Mutlu E; Gür Aksoy G; Topaloğlu Demir F; Karadağ AS
    J Cosmet Dermatol; 2023 Feb; 22(2):354-363. PubMed ID: 36575896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous adverse reactions of COVID-19 vaccines: A systematic review.
    Qaderi K; Golezar MH; Mardani A; Mallah MA; Moradi B; Kavoussi H; Shamsabadi A; Golezar S
    Dermatol Ther; 2022 May; 35(5):e15391. PubMed ID: 35194894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies.
    Baba A; Yamada K; Kanekura T
    J Dermatol; 2024 Jun; 51(6):827-838. PubMed ID: 38605482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective multicenter study on cutaneous reactions reported after Sinopharm COVID-19 vaccination.
    Shawky A; Elrewiny EM; Gharib K; Sallam M; Mansour M; Rageh MA
    Int J Dermatol; 2023 Feb; 62(2):221-224. PubMed ID: 35959522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.
    Washrawirul C; Triwatcharikorn J; Phannajit J; Ullman M; Susantitaphong P; Rerknimitr P
    J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):1947-1968. PubMed ID: 35666609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
    Johnston MS; Galan A; Watsky KL; Little AJ
    JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database.
    Falotico JM; Desai AD; Shah A; Ricardo JW; Lipner SR
    Am J Clin Dermatol; 2022 Sep; 23(5):729-737. PubMed ID: 35931925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: An observational study.
    Grieco T; Maddalena P; Sernicola A; Muharremi R; Basili S; Alvaro D; Cangemi R; Rossi A; Pellacani G
    Dermatol Ther; 2021 Nov; 34(6):e15153. PubMed ID: 34622531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics of cutaneous complications following COVID-19 vaccination: A case series.
    Diab R; Rakhshan A; Salarinejad S; Pourani MR; Ansar P; Abdollahimajd F
    J Cosmet Dermatol; 2024 Mar; 23(3):725-730. PubMed ID: 37899662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatological adverse reactions after vaccination with BNT162b2 in a cohort of healthcare workers.
    Ruiz-Villaverde R; Rivera-Izquierdo M; Gil-Villalba A; Pegalajar-García MD; Pérez-Rojas J; Soler-Iborte E; Valero-Ubierna MC
    Int J Dermatol; 2022 Oct; 61(10):1289-1293. PubMed ID: 35775137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous reactions to COVID-19 vaccine at the dermatology primary care.
    Burlando M; Herzum A; Micalizzi C; Cozzani E; Parodi A
    Immun Inflamm Dis; 2022 Feb; 10(2):265-271. PubMed ID: 34837354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea.
    Lee YW; Lim SY; Lee JH; Lim JS; Kim M; Kwon S; Joo J; Kwak SH; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH; Bae S
    J Korean Med Sci; 2021 May; 36(21):e153. PubMed ID: 34060261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active Symptom-Based Surveillance of Adverse Events Following Immunization Among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala.
    Jose M; Rajmohan P; Thomas J; Krishna S; Antony B; Gopinathan UU; Iyyapan EM; Porinchu RM; Jose P; Raphael L; Kuttichira P
    Curr Drug Saf; 2022; 17(4):327-334. PubMed ID: 35135453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous manifestations following COVID-19 vaccination: A report of 25 cases.
    Shakoei S; Kalantari Y; Nasimi M; Tootoonchi N; Ansari MS; Razavi Z; Etesami I
    Dermatol Ther; 2022 Aug; 35(8):e15651. PubMed ID: 35716105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.